Read More Pharma Industry News X4 Pharmaceuticals completes merger with Arsanis to advance rare disease and cancer treatments X4 Pharmaceuticals has finalised its merger with Arsanis, creating a late-stage biopharmaceutical company focused on tackling rare diseases… bypharmanewsdailyMarch 13, 2019